Modulation of glycosaminoglycan production and antithrombin III binding by cultured aortic endothelial cells treated with 4-methylumbelliferyl-beta-D-xyloside.
- 1 November 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 7 (6) , 627-636
- https://doi.org/10.1161/01.atv.7.6.627
Abstract
The interaction between antithrombin III and heparinlike glycosaminoglycan molecules present on the vascular surface seems to play a significant role in the regulation of coagulation. We have tested the hypothesis that altered synthesis of glycosaminoglycans by endothelial cells could influence this interaction by using 4-methylumbelliferyl-beta-D-xyloside for metabolic perturbation of glycosaminoglycan production. Incubation of purified porcine 125I-antithrombin III with cultured porcine aortic endothelial cells demonstrated specific, time-dependent, saturable binding of this protease inhibitor to the endothelial cell surface with antithrombin III concentration at half-maximal binding of approximately 40 nM. This binding was displaced by heparin and was completely abolished by selective removal of heparan sulfate from cells with heparitinase, indicating that antithrombin III binds to heparan sulfate on the surface of endothelial cells. Incubation of cell cultures with beta-D-xyloside resulted in a reduct...This publication has 30 references indexed in Scilit:
- Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells.Journal of Clinical Investigation, 1985
- Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity.Journal of Clinical Investigation, 1985
- Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.Journal of Clinical Investigation, 1984
- Anticoagulantly active heparin-like molecules from vascular tissueBiochemistry, 1984
- Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.Proceedings of the National Academy of Sciences, 1984
- Protein-C: biochemistry, physiology, and clinical implicationsBlood, 1983
- Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.Journal of Clinical Investigation, 1982
- Clearance of Thrombin from Circulation in Rabbits by High-affinity Binding Sites on EndotheliumJournal of Clinical Investigation, 1980
- Synthesis of fibrinolytic activator and inhibitor by endothelial cellsProceedings of the National Academy of Sciences, 1977
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951